The synthetic polymers and their combinations were employed to retard the release of nimesulide from microcapsules. Microcapsules were prepared in different ratios of Eudragit RL 100 and hydroxy propyl methyl cellulose (HPMC) separately and in combination. All formulations of microcapsules were compressed to tablets. Dissolution of microcapsules and their tablets was performed by USP-apparatus-II in 900 mL borate buffer of pH 8.4 at 37.0 ± 0.5 ºC, at 50 rpm. In vitro kinetics was determined by various models including Zero order, First Order, Higuchi, Korsmeyer-Peppas and Hixson-Crowell. Eudragit showed higher retarding effect over extended period of time on release of drug than HPMC alone or its combination with Eudragit.Colegio de Farmacé...
Nimesulide is a non-steroidal anti-inflammatory drug. Here, the present study was planned to prepare...
A predictive in vitro-invivo correlation (IVIVC) can empower in vitro dissolution as a surrogate for...
The aim of this study was to develop a single combined once-daily sustained release microencapsulate...
The synthetic polymers and their combinations were employed to retard the release of nimesulide from...
Nimesulide was formulated as sustained release microcapsules using biodegradable polymer Poly(D,L-l...
The aim of this study was to formulate ethyl cellulose (EC) microparticles for sustained release of ...
The present study involves the preparation of nimesulide-chitosan microparticles (NCM) as sustained ...
The aim of this study was to develop a single combined once-daily sustained release microencapsulat...
This presentation narrates the comparative analysis of the dissolution data nimesulide microparticle...
Purpose: To formulate prolonged-release floating microparticles that would minimise the irritant eff...
Nimesulide was formulated as novel dual coated microparticles using chitosan (CTN) and ethyl cellulo...
Purpose: To formulate prolonged-release floating microparticles that would minimise the irritant eff...
The objective of this study was to formulate and evaluate the drug-polymer interaction of mefenamic ...
The pharmaceutical innovations, such as the use of polymers to control drug release, create possibil...
Abstract: The concept of Fast Dissolving Drug Delivery System emerged from the desire to provide pat...
Nimesulide is a non-steroidal anti-inflammatory drug. Here, the present study was planned to prepare...
A predictive in vitro-invivo correlation (IVIVC) can empower in vitro dissolution as a surrogate for...
The aim of this study was to develop a single combined once-daily sustained release microencapsulate...
The synthetic polymers and their combinations were employed to retard the release of nimesulide from...
Nimesulide was formulated as sustained release microcapsules using biodegradable polymer Poly(D,L-l...
The aim of this study was to formulate ethyl cellulose (EC) microparticles for sustained release of ...
The present study involves the preparation of nimesulide-chitosan microparticles (NCM) as sustained ...
The aim of this study was to develop a single combined once-daily sustained release microencapsulat...
This presentation narrates the comparative analysis of the dissolution data nimesulide microparticle...
Purpose: To formulate prolonged-release floating microparticles that would minimise the irritant eff...
Nimesulide was formulated as novel dual coated microparticles using chitosan (CTN) and ethyl cellulo...
Purpose: To formulate prolonged-release floating microparticles that would minimise the irritant eff...
The objective of this study was to formulate and evaluate the drug-polymer interaction of mefenamic ...
The pharmaceutical innovations, such as the use of polymers to control drug release, create possibil...
Abstract: The concept of Fast Dissolving Drug Delivery System emerged from the desire to provide pat...
Nimesulide is a non-steroidal anti-inflammatory drug. Here, the present study was planned to prepare...
A predictive in vitro-invivo correlation (IVIVC) can empower in vitro dissolution as a surrogate for...
The aim of this study was to develop a single combined once-daily sustained release microencapsulate...